L T Gutman, J Schaller, R J Wedgwood. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Ampicillin/therapeutic useBacteria/growth & developmentChildErythromycin/therapeutic useFemaleHumansL Forms/drug effectsL Forms/growth & developmentLupus Erythematosus, Systemic/complicationsLupus Erythematosus, Systemic/drug therapyPenicillin ResistancePrednisolone/therapeutic useProteus/drug effectsProteus Infections/drug therapySulfisoxazole/therapeutic useUrinary CatheterizationUrinary Tract Infections/complicationsUrinary Tract Infections/drug therapy
Substances: See more » ErythromycinSulfisoxazoleAmpicillinPrednisolone
Year: 1967 PMID: 4164065 DOI: 10.1016/s0140-6736(67)91090-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321